GSA Capital Partners’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$684K Buy
11,434
+6,253
+121% +$374K 0.05% 708
2025
Q1
$272K Buy
5,181
+1,075
+26% +$56.4K 0.02% 1218
2024
Q4
$226K Sell
4,106
-4,412
-52% -$243K 0.02% 1357
2024
Q3
$428K Sell
8,518
-2,302
-21% -$116K 0.03% 1017
2024
Q2
$475K Buy
10,820
+3,119
+41% +$137K 0.03% 1000
2024
Q1
$339K Buy
+7,701
New +$339K 0.03% 1138
2019
Q3
Sell
-11,301
Closed -$231K 1543
2019
Q2
$231K Sell
11,301
-2,595
-19% -$53K 0.03% 1167
2019
Q1
$390K Buy
13,896
+2,100
+18% +$58.9K 0.04% 837
2018
Q4
$289K Buy
11,796
+1,500
+15% +$36.8K 0.03% 857
2018
Q3
$382K Buy
+10,296
New +$382K 0.02% 1208
2016
Q3
Sell
-9,902
Closed -$215K 1847
2016
Q2
$215K Sell
9,902
-26,330
-73% -$572K 0.01% 1537
2016
Q1
$694K Sell
36,232
-13,971
-28% -$268K 0.04% 782
2015
Q4
$1.41M Buy
50,203
+31,901
+174% +$894K 0.07% 460
2015
Q3
$446K Buy
+18,302
New +$446K 0.02% 1187